Board of Directors

Michael S. Poirier

President, CEO and Chairman

Michael S. Poirier founded Qualigen in 1996 and is its Chairman, President and Chief Executive Officer.  Prior to founding Qualigen, Mr. Poirier was Vice President of Marketing for Ashirus Technologies, Inc., a Minneapolis-based manufacturer of innovative high-precision dispensing pumps and related equipment for the medical industry.  From 1993 to 1995, Mr. Poirier was Director of US Area Operations for EnSys, Inc., located in Research Triangle, North Carolina.  EnSys developed and manufactured field-portable immunoassay test kits for the environmental remediation industry.  From 1991 to 1993, Mr. Poirier was employed by Sanofi Pasteur in Chaska, Minnesota, as a Marketing Manager responsible for launching the ACCESS® Immunoassay System.  This novel diagnostic system was later acquired by Beckman-Coulter and is now one of the leading immunoassay test systems worldwide.  From 1985 to 1991, Mr. Poirier was employed by Abbott Diagnostics, a division of Abbott Laboratories, Inc. in various marketing and sales positions, including Worldwide Immunoassay Product Manager for the IMx® and AxSym® immunoassay diagnostic systems.  Both IMx and later, AxSym, became the leaders in their respective markets.  Prior to working at Abbott, Mr. Poirier served as an officer in the United States Navy, assigned to the US Atlantic Fleet.  Mr. Poirier holds a B.A. from Providence College and attended the University of Zürich, Switzerland, School of Law.

Christopher L. Lotz

Chief Financial Officer, Director

Christopher L. Lotz joined Qualigen as Director of Finance in 2002 and was appointed Vice President and Chief Financial Officer in 2003.  Prior to joining Qualigen,  Mr. Lotz was Director of Finance for the United States subsidiaries of Bexcom, a procurement management software company based in Singapore from 1999 to 2001.  From 1998 to 1999 Mr. Lotz served as Controller of California Furniture Collections, Inc. a custom furniture manufacturer, and from 1987 to 1998 Mr. Lotz was Controller and then Vice President and Chief Financial Officer of Group Publishing, Inc. a book and magazine publisher.  Mr. Lotz holds a B.S. in Business Administration from Colorado State University.

Kurt H. Kruger


Mr. Kruger has enjoyed a 30-year career in Medical Technology. His deep involvement in the field has ranged from product design and development as a biomedical engineer to raising capital for, and following, publicly traded medical product companies as an equities research analyst. As a marketing manager at Guidant, now a part of Boston Scientific, he developed the launch plans for the first-ever implantable defibrillator. As a securities analyst he showed perspicuity leading Hambrecht & Quist in providing venture funds for, and then taking public, Ventritex, which was later acquired by St. Jude Medical. After Hambrecht & Quist, Kurt worked as an analyst for Montgomery Securities and Bank of America. Across 20 years of research work, Kurt has overseen the IPOs of over 30 medical products companies, including leadership of the Life Sciences banking effort for WR Hambrecht & Co.  Mr. Kruger received a Sc.B. degree in Biomedical Engineering from Brown University; a Master’s degree in Bioengineering from the University of Michigan and a business degree (S.M.) from the Sloan School at the Massachusetts Institute of Technology (MIT). He also completed the premedical post-baccalaureate program at Columbia University.

Richard A. David, M.D. FACS, MMM


Dr. Richard David serves as Chief Medical Officer for Skyline Urology, the largest Urology group in Los Angeles. He also serves as medical director for Skyline’s Advanced Prostate Cancer Center of Excellence.  In addition, Dr. David serves as Associate Clinical Professor of Urology for the David Geffen School of Medicine at UCLA.  He serves on the Attending Staff in Surgery/Urology at Harbor UCLA Medical Center and Olive View UCLA Medical Center.  He is certified by the American Board of Urology.  His clinical and research interests include minimally invasive endoscopic treatment for urologic diseases, sexual function and prosthetics, and advanced prostate cancer.  He has published extensively and presented at many international conferences in this area. He has received the “Super Doctor” designation 13 times.  Dr. David serves as Chief of Surgery at Motion Picture and Television Hospital (MPTVH) in Woodland Hills, CA.  In addition to MPTHV, Dr. David serves on staff at Providence St. Joseph Medical Center, Providence Tarzana Medical Center, Valley Presbyterian Hospital, Northridge Hospital Medical Center, Encino Hospital, Sherman Oaks Hospital, Harbor UCLA Medical Center and Olive View UCLA Medical Center.  Dr. David obtained his undergraduate education at Stanford University and his medical degree at Thomas Jefferson University in Philadelphia.  He also holds a Masters Degree in Medical Management (MMM) from the Marshall School of Business at the University of Southern California.  He trained in general surgery and completed his urology residency at UCLA Medical Center in Los Angeles. Dr. David is a fellow of the American College of Surgeons, a member of the American Urological Association, the American Medical Association, and the California Urologic Association.  He is also a member in the American Association of Clinical Urologists, American Lithotripsy Society, Society of Laparoendoscopic Surgeons and Society of Urologic Prosthetic Surgeons.